937 related articles for article (PubMed ID: 17550140)
1. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas.
Pan XC; Chen Z; Chen F; Chen XH; Jin HY; Xu XY
J Zhejiang Univ Sci B; 2006 Oct; 7(10):830-6. PubMed ID: 16972326
[TBL] [Abstract][Full Text] [Related]
3. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
4. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
[TBL] [Abstract][Full Text] [Related]
5. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
[TBL] [Abstract][Full Text] [Related]
6. Expression of the transcription factor Klf6 in cirrhosis, macronodules, and hepatocellular carcinoma.
Bureau C; Péron JM; Bouisson M; Danjoux M; Selves J; Bioulac-Sage P; Balabaud C; Torrisani J; Cordelier P; Buscail L; Vinel JP
J Gastroenterol Hepatol; 2008 Jan; 23(1):78-86. PubMed ID: 18171345
[TBL] [Abstract][Full Text] [Related]
7. [A candidate tumor suppressor gene mutated in primary hepatocellular carcinoma: kruppel-like factor 6].
Wang SP; Chen XP; Qiu FZ
Zhonghua Wai Ke Za Zhi; 2004 Oct; 42(20):1258-61. PubMed ID: 15598377
[TBL] [Abstract][Full Text] [Related]
8. KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis.
Sirach E; Bureau C; Péron JM; Pradayrol L; Vinel JP; Buscail L; Cordelier P
Cell Death Differ; 2007 Jun; 14(6):1202-10. PubMed ID: 17347668
[TBL] [Abstract][Full Text] [Related]
9. Genetic and epigenetic alterations of the KLF6 gene in hepatocellular carcinoma.
Song J; Kim CJ; Cho YG; Kim SY; Nam SW; Lee SH; Yoo NJ; Lee JY; Park WS
J Gastroenterol Hepatol; 2006 Aug; 21(8):1286-9. PubMed ID: 16872311
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
[TBL] [Abstract][Full Text] [Related]
11. KLF6: mutational analysis and effect on cancer cell proliferation.
Yin D; Komatsu N; Miller CW; Chumakov AM; Marschesky A; McKenna R; Black KL; Koeffler HP
Int J Oncol; 2007 Jan; 30(1):65-72. PubMed ID: 17143513
[TBL] [Abstract][Full Text] [Related]
12. In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma.
Narla G; Kremer-Tal S; Matsumoto N; Zhao X; Yao S; Kelley K; Tarocchi M; Friedman SL
Oncogene; 2007 Jun; 26(30):4428-34. PubMed ID: 17297474
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
[TBL] [Abstract][Full Text] [Related]
14. New candidate tumor-suppressor gene KLF6 and its splice variant KLF6 SV2 counterbalancing expression in primary hepatocarcinoma.
Zhenzhen Z; De'an T; Limin X; Wei Y; Min L
Hepatogastroenterology; 2012; 59(114):473-6. PubMed ID: 21940380
[TBL] [Abstract][Full Text] [Related]
15. Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma.
Kremer-Tal S; Reeves HL; Narla G; Thung SN; Schwartz M; Difeo A; Katz A; Bruix J; Bioulac-Sage P; Martignetti JA; Friedman SL
Hepatology; 2004 Nov; 40(5):1047-52. PubMed ID: 15486921
[TBL] [Abstract][Full Text] [Related]
16. Expression and clinical significance of p53, JunB and KAI1/CD82 in human hepatocellular carcinoma.
Guo C; Liu QG; Zhang L; Song T; Yang X
Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):389-96. PubMed ID: 19666408
[TBL] [Abstract][Full Text] [Related]
17. [Expression of NET-1 gene and protein in hepatocellular carcinoma and related tissues].
Chen L; Shen AG; Wang GL; Lu P; Li XY
Ai Zheng; 2006 Mar; 25(3):320-5. PubMed ID: 16536986
[TBL] [Abstract][Full Text] [Related]
18. Regulation of corneal keratin-12 gene expression by the human Krüppel-like transcription factor 6.
Chiambaretta F; Blanchon L; Rabier B; Kao WW; Liu JJ; Dastugue B; Rigal D; Sapin V
Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3422-9. PubMed ID: 12407152
[TBL] [Abstract][Full Text] [Related]
19. The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma.
Ikeguchi M; Iwamoto A; Taniguchi K; Katano K; Hirooka Y
J Exp Clin Cancer Res; 2005 Sep; 24(3):415-21. PubMed ID: 16270528
[TBL] [Abstract][Full Text] [Related]
20. Thyroid hormone receptors suppress pituitary tumor transforming gene 1 activity in hepatoma.
Chen RN; Huang YH; Yeh CT; Liao CH; Lin KH
Cancer Res; 2008 Mar; 68(6):1697-706. PubMed ID: 18339849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
